A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

NCT01886690 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Bilateral LASIK Surgery

Interventions

DRUG: carboxymethylcellulose sodium based new eye drop formulation
DRUG: carboxymethylcellulose sodium based eye drops

Sponsor

Allergan